Evidence map›Paper›PMID 28172519›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2017

RNA-Seq Analysis of Gene Expression, Viral Pathogen, and B-Cell/T-Cell Receptor Signatures in Complex Chronic Disease.

Jerome Bouquet, Jennifer L Gardy, Scott Brown, Jacob Pfeil, Ruth R Miller, Muhammad Morshed, Antonio Avina-Zubieta, Kam Shojania, Mark McCabe, Shoshana Parker and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Persistent Symptoms After Treatment of Lyme Disease.Infectious disease clinics of North America · 2022
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 3 countries.

Jerome BouquetDepartment of Laboratory Medicine, University of California, San Francisco, USA.
Jennifer L GardyCommunicable Disease Prevention and Control Services, British Columbia Centre for Disease Control, Vancouver, BC, Canada.
Scott BrownCanada's Michael Smith Genome Sciences Centre, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, Canada.
Jacob PfeilDepartment of Laboratory Medicine, University of California, San Francisco, USA.
Ruth R MillerSchool of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
Muhammad MorshedBritish Columbia Centre for Disease Control Public Health Laboratory, 655 W 12th Ave., Vancouver, British Columbia, Canada.
Antonio Avina-ZubietaDepartment of Medicine, Division of Rheumatology, University of British Columbia, Vancouver, BC, Canada.
Kam ShojaniaDepartment of Medicine, Division of Rheumatology, University of British Columbia, Vancouver, BC, Canada.
Mark McCabeCommunicable Disease Prevention and Control Services, British Columbia Centre for Disease Control, Vancouver, BC, Canada.
Shoshana ParkerCentre for Health Evaluation Outcome Sciences, Vancouver, Canada.
Miguel UyaguariCommunicable Disease Prevention and Control Services, British Columbia Centre for Disease Control, Vancouver, BC, Canada.
Scot FedermanDepartment of Laboratory Medicine, University of California, San Francisco, USA.
Patrick TangDepartment of Pathology, Sidra Medical and Research Centre, Doha, Qatar.
Ted SteinerDepartment of Medicine, Division of Infectious Diseases, University of British Columbia, Vancouver, Canada.
Michael OtterstaterCommunicable Disease Prevention and Control Services, British Columbia Centre for Disease Control, Vancouver, BC, Canada.
Rob HoltCanada's Michael Smith Genome Sciences Centre, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, Canada.
Richard MooreCanada's Michael Smith Genome Sciences Centre, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, Canada.
Charles Y ChiuDepartment of Laboratory Medicine, University of California, San Francisco, USA.
David M PatrickCommunicable Disease Prevention and Control Services, British Columbia Centre for Disease Control, Vancouver, BC, Canada.
Complex Chronic Disease Study Group
University of British Columbia · CAUniversity of California, San Francisco · USBC Centre for Disease Control · CACanada's Michael Smith Genome Sciences Centre · CABC Cancer Agency · CACentre for Advancing Health Outcomes · CASidra Medical and Research Center · QA

Funding

Pan-Genomic Approaches for Comprehensive Blood Screening of Novel or Emerging Infectious AgentsR01HL105704 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHIU, CHARLES YEN · 2011 to 2020
$5.9M
NHLBI NIH HHS R01 HL105704
6 · The paper itself

Abstract

Background: Chronic fatigue syndrome (CFS) remains poorly understood. Although infections are speculated to trigger the syndrome, a specific infectious agent and underlying pathophysiological mechanism remain elusive. In a previous study, we described similar clinical phenotypes in CFS patients and alternatively diagnosed chronic Lyme syndrome (ADCLS) patients—individuals diagnosed with Lyme disease by testing from private Lyme specialty laboratories but who test negative by reference 2-tiered serologic analysis. Methods: Here, we performed blinded RNA-seq analysis of whole blood collected from 25 adults diagnosed with CFS and 13 ADCLS patients, comparing these cases to 25 matched controls and 11 patients with well-controlled systemic lupus erythematosus (SLE). Samples were collected at patient enrollment and not during acute symptom flares. RNA-seq data were used to study host gene expression, B-cell/T-cell receptor profiles (BCR/TCR), and potential viral infections. Results: No differentially expressed genes (DEGs) were found to be significant when CFS or ADCLS cases were compared to controls. Forty-two DEGs were found when SLE cases were compared to controls, consistent with activation of interferon signaling pathways associated with SLE disease. BCR/TCR repertoire analysis did not show significant differences between CFS and controls or ADCLS and controls. Finally, viral sequences corresponding to anelloviruses, human pegivirus 1, herpesviruses, and papillomaviruses were detected in RNA-seq data, but proportions were similar (P = .73) across all genus-level taxonomic categories. Conclusions: Our observations do not support a theory of transcriptionally mediated immune cell dysregulation in CFS and ADCLS, at least outside of periods of acute symptom flares.

Indexed as

Gene ExpressionAmino Acid MotifsAmino Acid SequenceB-LymphocytesCase-Control StudiesChronic DiseaseDisease SusceptibilityFatigue Syndrome, ChronicFemaleGene Expression ProfilingGenetic Predisposition to DiseaseHigh-Throughput Nucleotide SequencingHost-Pathogen InteractionsHumansLyme DiseaseMaleReceptors, Antigen, B-CellReceptors, Antigen, T-CellB-cell/T-cell receptorschronic fatigue syndromeRNA-seqtranscriptomeviral infection

Identifiers

PMID28172519
PMCPMC5850034
OpenAlexW2587139687

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.